SMNR (SMNR)
0.74
+0.10 (15.62%)
Upcoming Events
Latest Headlines
Form 424B3 Semnur Pharmaceuticals,
July 7, 2026 10:49 AM - SEC Filing
Form 8-K Semnur Pharmaceuticals, For: Jul 03
July 7, 2026 10:41 AM - SEC Filing
Semnur signs $100M binding term sheet with Kazakhstan investor
July 7, 2026 6:00 AM - StreetInsider
Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), Announces Signing of Binding Term Sheet for Proposed $100 Million Strat
July 7, 2026 6:00 AM - Globe NewsWire
Form 424B3 Semnur Pharmaceuticals,
July 1, 2026 6:07 AM - SEC Filing
Form SCHEDULE 13D/A Semnur Pharmaceuticals, Filed by: Scilex Holding Co
June 26, 2026 4:24 PM - SEC Filing
Form 4 Semnur Pharmaceuticals, For: Jun 15 Filed by: Scilex Holding Co
June 26, 2026 4:20 PM - SEC Filing
Form 8-K Semnur Pharmaceuticals, For: Jun 25
June 25, 2026 5:04 PM - SEC Filing
Form 424B3 Semnur Pharmaceuticals,
June 15, 2026 5:02 PM - SEC Filing
Form 424B3 Semnur Pharmaceuticals,
June 15, 2026 7:00 AM - SEC Filing
Scilex confirms June 15 dividend payment date for Semnur stock distribution
June 12, 2026 7:45 AM - StreetInsider
Scilex sets June 15 payment date for Semnur stock dividend
June 4, 2026 9:01 AM - StreetInsider
Scilex approves dividend of Semnur shares to stockholders
May 22, 2026 1:15 PM - StreetInsider
Scilex Holding Company (“Scilex”) Announces Its Board of Directors Approved a Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Secu
May 22, 2026 1:15 PM - Globe NewsWire
Form POS AM Semnur Pharmaceuticals,
May 12, 2026 4:42 PM - SEC Filing
Form ARS Semnur Pharmaceuticals, For: Dec 31
April 30, 2026 4:55 PM - SEC Filing
Form DEF 14A Semnur Pharmaceuticals, For: Jun 25
April 30, 2026 4:51 PM - SEC Filing
Full Article List
